Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 27;13(3):772.
doi: 10.3390/nu13030772.

Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?

Affiliations
Review

Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?

Alessia Alunno et al. Nutrients. .

Abstract

In recent years, an increasing interest in the influence of diet in rheumatic and musculoskeletal diseases (RMDs) led to the publication of several articles exploring the role of food/nutrients in both the risk of developing these conditions in normal subjects and the natural history of the disease in patients with established RMDs. Diet may be a possible facilitator of RMDs due to both the direct pro-inflammatory properties of some nutrients and the indirect action on insulin resistance, obesity and associated co-morbidities. A consistent body of research has been conducted in rheumatoid arthritis (RA), while studies in systemic lupus erythematosus (SLE) are scarce and have been conducted mainly on experimental models of the disease. This review article aims to outline similarities and differences between RA and SLE based on the existing literature.

Keywords: Mediterranean diet; cardiovascular risk; polyunsaturated fatty acids; rheumatoid arthritis; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Heidemann C., Schulze M.B., Franco O.H., Van Dam R.M., Mantzoros C.S., Hu F.B. Dietary Patterns and Risk of Mortality From Cardiovascular Disease, Cancer, and All Causes in a Prospective Cohort of Women. Circ. 2008;118:230–237. doi: 10.1161/CIRCULATIONAHA.108.771881. - DOI - PMC - PubMed
    1. Kostopoulou M., Nikolopoulos D., Parodis I., Bertsias G. Cardiovascular Disease in Systemic Lupus Erythematosus: Recent data on epidemiology, risk factors and prevention. Curr. Vasc. Pharmacol. 2020;18:1. doi: 10.2174/1570161118666191227101636. - DOI - PubMed
    1. Hansildaar R., Vedder D., Baniaamam M., Tausche A.-K., Gerritsen M., Nurmohamed M.T. Cardiovascular risk in inflammatory arthritis: Rheumatoid arthritis and gout. Lancet Rheumatol. 2021;3:e58–e70. doi: 10.1016/S2665-9913(20)30221-6. - DOI - PMC - PubMed
    1. Agca R., Heslinga S.C., Rollefstad S., Heslinga M., McInnes I.B., Peters M.J.L., Kvien T.K., Dougados M., Radner H., Atzeni F., et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann. Rheum. Dis. 2017;76:17–28. doi: 10.1136/annrheumdis-2016-209775. - DOI - PubMed
    1. Semb A.G., Ikdahl E., Wibetoe G., Crowson C., Rollefstad S. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat. Rev. Rheumatol. 2020;16:361–379. doi: 10.1038/s41584-020-0428-y. - DOI - PubMed

LinkOut - more resources